Capricor Therapeutics, Inc.
Get Full AccessDescription
- Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other medical conditions. Capricor's lead candidate, CAP-1002, is a cardiac cell therapy that is currently being evaluated for the treatment of heart disease associated with Duchenne muscular dystrophy and myocardial infarction (heart attack). In addition, the Company is conducting research and development on its exosomes (CAP-2003) platform technology for cardiac diseases and other potential indications.
-
Headquarters:8840 Wilshire Boulevard , Los Angeles, California, United States
More -
Phone Number: +1 310-358-3200
-
Website: https://www.capricor.com
-
Employees:29
-
Revenue:$10 - 50M
-
Legal Name:Capricor Therapeutics, Inc.
-
Capricor Therapeutics, Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 541714 |
Show More
Frequently Asked Questions regarding Capricor Therapeutics, Inc.
-
Where are Capricor Therapeutics, Inc.'s Headquarters?
Capricor Therapeutics, Inc.'s Headquarters are in 8840 Wilshire Boulevard ,Los Angeles,California,United States
-
What is Capricor Therapeutics, Inc.'s phone number?
Capricor Therapeutics, Inc.'s phone number is +1 310-358-3200
-
What is Capricor Therapeutics, Inc.'s official website?
Capricor Therapeutics, Inc.'s official website is https://www.capricor.com
-
What is Capricor Therapeutics, Inc.'s Revenue?
Capricor Therapeutics, Inc.'s revenue is $10 - 50M
-
What is Capricor Therapeutics, Inc.'s NAICS code?
Capricor Therapeutics, Inc.'s NAICS code is 541714
-
How many employees are working in Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. has 29 employees
-
What is Capricor Therapeutics, Inc.'s Industry?
Capricor Therapeutics, Inc. is in the industry of Biotechnology
-
Who is Capricor Therapeutics, Inc.'s CEO?
Capricor Therapeutics, Inc.'s CEO is Linda Marban

